Identification of two distinct pathways of human myelopoiesis by Drissen, R, Thongjuea, S, Theilgaard-Mönch, K, Nerlov, C

Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency by Hasemann, MS, Schuster, M, Frank, A, Theilgaard-Mönch, K, Pedersen, T, Nerlov, C, Porse, B

Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. by Porse, B, Bryder, D, Theilgaard-Mönch, K, Hasemann, MS, Anderson, K, Damgaard, I, Jacobsen, SE, Nerlov, C

NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. by Weischenfeldt, J, Damgaard, I, Bryder, D, Theilgaard-Mönch, K, Thoren, L, Nielsen, F, Jacobsen, SE, Nerlov, C, Porse, B

Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen. by Hasemann, MS, Damgaard, I, Schuster, M, Theilgaard-Mönch, K, Sørensen, AB, Mrsic, A, Krugers, T, Ylstra, B, Pedersen, F, Nerlov, C, Porse, B

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients by Jensen O, Øvlisen AK, Jakobsen LH, Roug AS, Nielsen RE, Marcher CW, Ebbesen Lh, Theilgaard-Mönch K, Møller P, Schöllkopf C, Torp-Pedersen C, El-Galaly TC, Severinsen MT

Get full text

Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. by Kirstetter, P, Schuster, M, Bereshchenko, O, Moore, S, Dvinge, H, Kurz, E, Theilgaard-Mönch, K, Månsson, R, Pedersen, T, Pabst, T, Schrock, E, Porse, B, Jacobsen, SE, Bertone, P, Tenen, D, Nerlov, C

Gene expression profiling in MDS and AML: potential and future avenues. by Theilgaard-Mönch, K, Boultwood, J, Ferrari, S, Giannopoulos, K, Hernandez-Rivas, J, Kohlmann, A, Morgan, M, Porse, B, Tagliafico, E, Zwaan, C, Wainscoat, J, Van den Heuvel-Eibrink, MM, Mills, K, Bullinger, L

The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. by Nilsson, L, Edén, P, Olsson, E, Månsson, R, Astrand-Grundström, I, Strömbeck, B, Theilgaard-Mönch, K, Anderson, K, Hast, R, Hellström-Lindberg, E, Samuelsson, J, Bergh, G, Nerlov, C, Johansson, B, Sigvardsson, M, Borg, A, Jacobsen, SE

The EHA Research Roadmap: normal hematopoiesis by Jaffredo, T, Balduini, A, Bigas, A, Bernardi, R, Bonnet, D, Canque, B, Charbord, P, Cumano, A, Delwel, R, Durand, C, Fibbe, W, Forrester, L, de Franceschi, L, Ghevaert, C, Gjertsen, B, Gottgens, B, Graf, T, Heidenreich, O, Hermine, O, Higgs, D, Kleanthous, M, Klump, H, Kouskoff, V, Krause, D, Lacaud, G, Celso, CL, Martens, JHA, Méndez-Ferrer, S, Menendez, P, Oostendorp, R, Philipsen, S, Porse, B, Raaijmakers, M, Robin, C, Stunnenberg, H, Theilgaard-Mönch, K, Touw, I, Vainchenker, W, Corrons, J-LV, Yvernogeau, L, Schuringa, JJ